Results 1 to 10 of about 266,419 (208)

Clinical Utility of Cardiac Troponin I and Cardiac Troponin T Measurements [PDF]

open access: yesActa Medica, 1997
The measurement of CK-MB remains the test of choice for confirmation or exclusion of AMI and probably will remain the test of choice for routine diagnosis in the near future.
Michaela Adamcová   +2 more
doaj   +3 more sources

Association between admission high-sensitivity cardiac troponin T levels and clinical outcomes in acute intracerebral hemorrhage: a prospective cohort study [PDF]

open access: yesBMC Neurology
Background Intracerebral hemorrhage remains one of the most devastating forms of stroke, associated with high mortality and disability. Cardiac injury following ICH, mediated through the brain-heart axis, may serve as a marker of disease severity.
Quoc Viet Bui   +8 more
doaj   +2 more sources

Cardiac Troponin T and Troponin I in the General Population.

open access: yesCirculation, 2019
There is great interest in widening the use of high-sensitivity cardiac troponins for population cardiovascular disease (CVD) and heart failure screening. However, it is not clear whether cardiac troponin T (cTnT) and troponin I (cTnI) are equivalent measures of risk in this setting. We aimed to compare and contrast (1) the association of cTnT and cTnI
Welsh P   +14 more
openaire   +4 more sources

Cardiac troponin T as a serum biomarker of respiratory impairment in amyotrophic lateral sclerosis [PDF]

open access: yesAnnals of Clinical and Translational Neurology
Objective Informative biomarkers are an urgent need in the management of amyotrophic lateral sclerosis. Serum cardiac troponin T is elevated in the majority of amyotrophic lateral sclerosis patients and increases with disease progression.
Teresa Koch   +8 more
doaj   +2 more sources

Cardiac Sarcoidosis and Troponin T-Related Cardiomyopathy

open access: yesJACC: Case Reports
Background: Cardiac sarcoidosis and genetic cardiomyopathy are both rare causes of heart disease with often similar presentations that can be difficult to diagnose.
Alec Chu Ming Yu, MD   +5 more
doaj   +3 more sources

Skeletal Muscle Disorders: A Noncardiac Source of Cardiac Troponin T

open access: yesCirculation, 2022
Background: Cardiac troponin (cTn) T and cTnI are considered cardiac specific and equivalent in the diagnosis of acute myocardial infarction. Previous studies suggested rare skeletal myopathies as a noncardiac source of cTnT.
J. du Fay de Lavallaz   +29 more
semanticscholar   +1 more source

Cardiac biomarkers and COVID-19: A systematic review and meta-analysis

open access: yesJournal of Infection and Public Health, 2021
Objective: To systematically investigate the relationship between cardiac biomarkers and COVID-19 severity and mortality. Methods: We performed a literature search using PubMed, Web of Science, and Google Scholar.
Wen An   +3 more
doaj   +1 more source

Effects of high-intensity interval exercise on cardiac troponin elevation when comparing with moderate-intensity continuous exercise: a systematic review and meta-analysis [PDF]

open access: yesPeerJ, 2023
Background This systematic review and meta-analysis aimed to compare the effects of high-intensity interval exercise (HIIE) with different recovery modes versus moderate-intensity continuous exercise (MICE) on cardiac troponin (cTn) elevation ...
Shuoqi Li   +5 more
doaj   +2 more sources

Prognostic value of high-sensitive cardiac troponin-T in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention in Erbil cardiac center

open access: yesAdvanced Medical Journal, 2023
Background and objectives: Background and objectives: Patients with ST-segment elevation myocardial infarction have higher rates of major adverse cardiovascular events including deaths, and it is recommended that these patients should undergo primary ...
Hewa Mohammed Hamad Ameen   +1 more
doaj   +1 more source

Home - About - Disclaimer - Privacy